Puma Biotechnology (PBYI) PT Raised to $9 at Goldman Sachs
Tweet
Share
E-mailGet Alerts PBYI Hot Sheet
Price: $8.53 +1.55%
Rating Summary:
5 Buy, 6 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 12 | New: 12
Rating Summary:
5 Buy, 6 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 12 | New: 12
Join SI Premium – FREE
Goldman Sachs analyst Paul Choi raised the price target on Puma Biotechnology (NASDAQ: PBYI) to $9.00 (from $8.00) while maintaining a Sell rating.
You May Also Be Interested In
- RBC Capital Downgrades Cochlear Ltd. (COH:AU) to Sector Perform
- Angel One Ltd (ANGELONE:IN) PT Raised to INR380 at Kotak
- ITC Hotels (ITCHOTEL:IN) PT Raised to INR235 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
